Announcement of Resolutions of the Third Extraordinary Shareholders Meeting of Kanghui Shares in 2026
Securities code: 603139 Securities abbreviation: Kanghui Shares Announcement number: 2026-046 Shaanxi Kanghui Pharmaceutical Co., Ltd.
Announcement of Resolutions of the Third Extraordinary Shareholders Meeting in 2026
The company and all members of the board of directors guarantee that there are no false records, misleading statements or major omissions in the announcement content, and assume legal responsibility for the authenticity, accuracy and completeness of its content.
Important content reminder:
Is there any veto resolution at this meeting: None
1. Meeting convening and attendance
(1) Time of the shareholders’ meeting: June 18, 2026
(2) The location of the shareholders’ meeting: Conference Room on the 10th floor of Shiji Technology Building, No. 17 Chaoqian Road, Changping District, Beijing
(3) Common shareholders attending the meeting and preference shareholders whose voting rights have been restored and their holdings:
Number of shareholders and proxies attending the meeting 95
Total number of shares with voting rights held by shareholders attending the meeting (shares) 34,243,137
The number of voting shares held by shareholders attending the meeting accounts for the total number of voting shares of the company.
Proportion of 38.0936 numbers (%)
(4) Whether the voting method complies with the provisions of the "Company Law" and the "Articles of Association", the status of the meeting, etc.
This shareholders' meeting was convened by the company's board of directors and held through a combination of on-site and online voting. The on-site meeting was chaired by Mr. Li Hongming, chairman of the company. The convening, holding and decision-making procedures of this shareholders' meeting comply with the provisions of the Company Law and the Articles of Association.
(5) Attendance of company directors and board secretary
The company has 9 current directors and 9 people are present.
Ms. Dong Juan, Secretary of the Board of Directors, attended this meeting; senior managers of the company and witness lawyers hired by the company
Teachers attended this shareholders meeting.
2. Proposal review status
(1) Non-cumulative voting proposals
- Proposal Name: Proposal on the establishment of wholly-owned subsidiaries with overseas investment and holding subsidiaries
Review result: Passed
Voting status:
Agree Disagree Abstain
Shareholder type
Proportion Proportion Proportional number of votes Number of votes Number of votes
(%) (%) (%)
A shares 34,241,537 99.9953 600 0.0017 1,000 0.0030
- Proposal Name: Proposal on the "Company's 2026 Restricted Stock Incentive Plan (Draft)" and its summary
Review result: Passed
Voting status:
Agree Disagree Abstain
Shareholder type
Proportion Proportion Proportional number of votes Number of votes Number of votes
(%) (%) (%)
A shares 34,215,537 99.9193 21,600 0.0630 6,000 0.0177
- Proposal Name: Proposal on the "Measures for the Implementation Assessment and Management of the Company's 2026 Restricted Stock Incentive Plan"
Review result: Passed
Voting status:
Agree Disagree Abstain
Shareholder type
Proportion Proportion Proportional number of votes Number of votes Number of votes
(%) (%) (%) A shares 34,220,537 99.9340 21,600 0.0630 1,000 0.0030
- Proposal Name: Proposal on Proposing to the Shareholders Meeting to Authorize the Board of Directors to Handle Matters Related to the Company’s 2026 Restricted Stock Incentive Plan
Review result: Passed
Voting status:
Agree Disagree Abstain
Shareholder type
Proportion Proportion Proportional number of votes Number of votes Number of votes
(%) (%) (%) A shares 34,210,537 99.9047 21,600 0.0630 11,000 0.0323
(2) When major matters are involved, the voting status of shareholders below 5%
- Non-cumulative voting proposals
discuss
Agree Objection Abstain
Motion name
order proportion proportion proportion
Number of votes Number of votes Number of votes (%) (%) (%) Regarding the "Company's 2026 Deadline"
Statutory stock incentive plan
2 847,300 96.8453 21,600 2.4688 6,000 0.6859 (draft)" and its summary
motion
About "Company's 2026 Expiration Date"
Implementation of statutory stock incentive plan
3 852,300 97.4168 21,600 2.4688 1,000 0.1144 Implementation Assessment Management Measures
motion
Regarding the request for authorization from the shareholders’ meeting
Board of Directors Management Company 2026
4 842,300 96.2738 21,600 2.4688 11,000 1.2574 annual restricted stock incentive plan
Proposals on planning related matters
(3) Explanation of relevant circumstances regarding voting on motions
Proposals 2, 3 and 4 are special resolutions, and these three proposals have been passed by more than 2/3 of the total number of shares with valid voting rights;
Proposals 2, 3 and 4 require separate counting of votes for small and medium investors;
The shareholders who are intended to be the target of this equity incentive or the shareholders who are related to the incentive target have abstained from voting on the above-mentioned proposals 2, 3 and 4;
All motions this time were voted on.
3. Lawyer’s testimony
(1) Law firm witnessing this shareholder meeting: Beijing King & Wood Mallesons Shanghai Branch
Lawyers: Shen Chengmin, Lu Pintian
(2) Lawyer’s concluding comments:
Our lawyers believe that the company’s convening and convening procedures of this shareholders’ meeting comply with the provisions of the Company Law, Securities Law and other relevant laws, administrative regulations, Shareholders’ Meeting Rules and Articles of Association; the qualifications of the persons attending this shareholders’ meeting and the convener are legal and valid; the voting procedures and voting results of this shareholders’ meeting are legal and valid.
Announcement is hereby made.
Shaanxi Kanghui Pharmaceutical Co., Ltd. Board of Directors
June 19, 2026